FNKLX | VIVIX | FNKLX / VIVIX | |
Total Expense Ratio | 0.00 | 0.04 | - |
Annual Report Gross Expense Ratio | 0.00 | 0.04 | - |
Fund Existence | 13 years | 27 years | - |
Gain YTD | 9.292 | 9.202 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14.4B | 208B | 7% |
Annual Yield % from dividends | 2.28 | 2.09 | 109% |
Returns for 1 year | 2.48 | 3.99 | 62% |
Returns for 3 years | 26.42 | 44.12 | 60% |
Returns for 5 years | 44.79 | 70.92 | 63% |
Returns for 10 years | 62.21 | 128.18 | 49% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XC | 34.93 | 0.22 | +0.63% |
WisdomTree True Emerging Markets ETF | |||
FDTS | 54.86 | N/A | N/A |
First Trust DevMkts exUS SC AlphaDEX®ETF | |||
SEPP | 29.76 | -0.11 | -0.36% |
PGIM S&P 500 Buffer 12 ETF - Sep | |||
FDIS | 99.56 | -1.07 | -1.06% |
Fidelity MSCI Consumer Discret ETF | |||
ATMP | 27.38 | -0.35 | -1.26% |
Barclays ETN+ Select MLP |